# Quidel to acquire Ortho Clinical Diagnostics for $6 billion

Quidel Corporation signed a definitive agreement to acquire Ortho Clinical Diagnostics for $24.68 per share, representing an equity value of approximately $6.0 billion. The transaction is expected to close in the first half of fiscal year 2022.

- Type: Acquisition
- Announced: 2021-12-22
- Value: $6.00B
- Status: announced
- Products: in vitro diagnostics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Quidel](https://endata.com/companies/27253.md) (acquirer)
- [Ortho Clinical Diagnostics](https://endata.com/companies/59868.md) (target)

## Sources

- [quidelortho.com](https://www.quidelortho.com/global/en/resources/press-releases/quidel-corporation-signs-definitive-agreement-to-acquire-ortho-c), 2021-12-22: "The combination with Ortho will help solidify Quidel as a leader in the diagnostics industry, bringing together innovative, complementary products, solutions, and services that enhance the health and well-being of patients across the globe."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.